Number of Patients in the Analysis of Efficacy With Various Contraindications for Preoperative ABD in Both Groups
Contraindications . | Epoetin Beta (n = 36) . | Placebo (n = 36) . |
---|---|---|
Aortic valve stenosis | 12 | 6 |
LVEF < 40% | 10 | 10 |
Left coronary main stem stenosis > 50% | 7 | 1 |
Myocardial infarction < 6 months preoperatively | 8 | 13 |
Heart failure stage NYHA III-IV | 9 | 8 |
History of unstable angina pectoris | 5 | 3 |
Exercise capacity < 70 W | 7 | 5 |
Severe cardiac arrhythmias | 5 | 4 |
History of TIA or syncope | 2 | 0 |
Heart rate < 55/min | 0 | 1 |
Pronounced lung disease | 0 | 1 |
Contraindications . | Epoetin Beta (n = 36) . | Placebo (n = 36) . |
---|---|---|
Aortic valve stenosis | 12 | 6 |
LVEF < 40% | 10 | 10 |
Left coronary main stem stenosis > 50% | 7 | 1 |
Myocardial infarction < 6 months preoperatively | 8 | 13 |
Heart failure stage NYHA III-IV | 9 | 8 |
History of unstable angina pectoris | 5 | 3 |
Exercise capacity < 70 W | 7 | 5 |
Severe cardiac arrhythmias | 5 | 4 |
History of TIA or syncope | 2 | 0 |
Heart rate < 55/min | 0 | 1 |
Pronounced lung disease | 0 | 1 |
Fifteen epoetin beta and 21 placebo patients had 1 contraindication. Two contraindications were present in 14 patients in each group, 3 contraindications in 6 epoetin beta patients and 1 placebo patient. Four contraindications were observed in 1 epoetin beta patient.
Abbreviation: TIA, transient ischemic attack.